2,163
Views
0
CrossRef citations to date
0
Altmetric
Supplement 1, 2015: Psychotrauma update - selected abstracts

Substance use disorders, trauma, and PTSD

Article: 27632 | Published online: 08 Apr 2015

References

  • Brady K. T., Killeen T. K., Brewerton T., Lucerini S. Comorbidity of psychiatric disorders and posttraumatic stress disorder. Journal of Clinical Psychology. 2000; 6(Suppl. 7): 22–32.
  • Brady K. T., Sonne S., Anton R. F., Randall C. L., Back S. E., Simpson K. Sertraline in the treatment of co-occurring alcohol dependence and posttraumatic stress disorder. Alcoholism: Clinical and Experimental Research. 2005; 29: 395–401.
  • Brown P. J., Stout R. L., Gannon-Rowley J. Substance use disorder-PTSD comorbidity. Patients’ perceptions of symptom interplay and treatment issues. Journal of Substance Abuse Treatment. 1998; 15: 445–448.
  • Kessler R. C., Sonnega A., Bromet E., Hughes M., Nelson C. B. Posttraumatic stress disorder in the National Comorbidity Survey. Archives of General Psychiatry. 1995; 52: 1048–1060.
  • Langeland W., Draijer N., Van den Brink W. Trauma and dissociation in treatment-seeking alcoholics: Towards a resolution of inconsistent findings. Comprehensive Psychiatry. 2002; 43: 195–203.
  • Najavits L. M., Hien D. Helping vulnerable populations: A comprehensive review of the treatment outcome literature on substance use disorder and PTSD. Journal of Clinical Psychology. 2013; 69: 433–479.
  • Nappi C. M., Drummond S. P., Hall J. M. Treating nightmares and insomnia in posttraumatic stress disorder: A review of current evidence. Neuropharmacology. 2012; 62: 576–585.
  • Norman S. B., Myers U. S., Wilkins K. C., Goldsmith A. A., Hristova V., Huang Z., etal. Review of biological mechanisms and pharmacological treatments of comorbid PTSD and substance use disorder. Neuropharmacology. 2012; 62: 542–551.
  • Sartor C. E., McCutcheon V. V., Pommer N. E., Nelson E. C., Grant J. D., Duncan A. E., etal. Common genetic and environmental contributions to post-traumatic stress disorder and alcohol dependence in young women. Psychological Medicine. 2011; 41: 1497–1505.
  • Schäfer I., Verthein U., Oechsler H., Deneke C., Riedel-Heller S., Martens M. What are the needs of alcohol dependent patients with a history of sexual violence? A case-register study in a metropolitan region. Drug and Alcohol Dependence. 2009; 105: 118–125.
  • Schäfer I., Gromus L., Atabaki A., Pawils S., Verthein U., Reimer J., etal. Are experiences of sexual violence related to special needs in patients with substance use disorders? A study in opioid-dependent patients. Addictive Behaviors. 2014; 39: 1691–1694.
  • Simpson T. L., Saxon A. J., Meredith C. W., Malte C. A., McBride B., Ferguson L. C., etal. A pilot trial of the alpha-1 adrenergic antagonist, prazosin, for alcohol dependence. Alcoholism: Clinical and Experimental Research. 2009; 33: 255–263.
  • Van Dam D., Ehring T., Vedel E., Emmelkamp P. M. Validation of the primary care posttraumatic stress disorder screening questionnaire (PC-PTSD) in civilian substance use disorder patients. Journal of Substance Abuse Treatment. 2010; 39: 105–113.
  • Van Dam D., Vedel E., Ehring T., Emmelkamp P. M. Psychological treatments for concurrent posttraumatic stress disorder and substance use disorder: A systematic review. Clinical Psychology Review. 2012; 32: 202–214.
  • Van den Brink W. Evidence-based pharmacological treatment of substance use disorders and pathological gambling. Current Drug Abuse Reviews. 2012; 5: 3–31.